DOKTER GENEVIEVE VANDERSTIGGEL (NEFROLOGIE) – DOKTER GEERT BOSMA (PSYCHIATRIE)
0466.510.216 · rovalta.com · 28/09/2026
DOKTER GENEVIEVE VANDERSTIGGEL (NEFROLOGIE) – DOKTER GEERT BOSMA (PSYCHIATRIE)
Company — Normal situation.
Strike-off: 09 septembre 2026
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODOKTER GENEVIEVE VANDERSTIGGEL (NEFROLOGIE) – DOKTER GEERT BOSMA (PSYCHIATRIE) is a Private limited company incorporated in 1999.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0466.510.216
- Incorporation
- 09/07/1999
- Legal form
- Private limited company
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 20 filingsTrend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 180,7 k € | -36.9% | 286,3 k € | +438% | 53,2 k € | +6.6% | 49,9 k € | -71.5% | 175,3 k € |
| EBITDA | 179,9 k € | -37.0% | 285,7 k € | +442% | 52,7 k € | +6.9% | 49,3 k € | -71.8% | 174,7 k € |
| Operating result | 179,9 k € | -36.9% | 285,2 k € | +452% | 51,6 k € | +10.2% | 46,8 k € | -72.8% | 172 k € |
| Net result | 124,1 k € | -37.3% | 198,1 k € | +463% | 35,2 k € | +14.8% | 30,6 k € | -73.6% | 116,2 k € |
| Balance sheet | |||||||||
| Equity | 654,6 k € | +23.4% | 530,5 k € | +59.6% | 332,5 k € | +4.1% | 319,3 k € | +10.6% | 288,7 k € |
| Total assets | 654,6 k € | +23.1% | 531,7 k € | +53.7% | 345,9 k € | -1.5% | 351 k € | -0.6% | 353 k € |
| Cash | 438,1 k € | +104% | 215 k € | -3.5% | 222,7 k € | -19.0% | 274,9 k € | +61.2% | 170,5 k € |
| Debts | 0 € | -100% | 83,9 € | -99.3% | 12,7 k € | -57.5% | 30 k € | -51.4% | 61,7 k € |
Board of directors
Source · NBB, accounts to 31/12/20252 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
GENEVIEVE VANDERSTIGGEL | DirectorManagersince 09/07/1999ended | |
Geert Bosma | DirectorManagerended |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Genevieve VanderStiggel | Manager |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 02/07/2026 | 01/07/2025 | 17/06/2024 | 04/07/2023 | 30/06/2022 | 24/06/2021 |
| General meeting | 20/06/2026 | 21/06/2025 | 15/06/2024 | 17/06/2023 | 18/06/2022 | 19/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 20/06/2026 | 02/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 21/06/2025 | 01/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 15/06/2024 | 17/06/2024 | Dutch | |
| Micro model | 31/12/2022 | 17/06/2023 | 04/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 18/06/2022 | 30/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 19/06/2021 | 24/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 20/06/2020 | 20/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 12/07/2019 | 24/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 24/07/2018 | 15/08/2018 | Dutch | |
| Abridged model | 01/07/2016 | 03/12/2016 | 13/01/2017 | Dutch | |
| Abridged model | 01/07/2015 | 18/05/2016 | 19/05/2016 | Dutch | |
| Abridged model | 01/07/2014 | 20/12/2014 | 14/01/2015 | Dutch | |
| Abridged model | 01/07/2013 | 28/01/2014 | 18/02/2014 | Dutch | |
| Abridged model | 01/07/2012 | 25/02/2013 | 27/02/2013 | Dutch | |
| Abridged model | 01/07/2011 | 21/02/2012 | 23/02/2012 | Dutch | |
| Abridged model | 01/07/2010 | 18/03/2011 | 24/03/2011 | Dutch | |
| Abridged model | 01/07/2009 | 18/02/2010 | 19/02/2010 | Dutch | |
| Abridged model | 01/07/2008 | 31/01/2009 | 26/02/2009 | Dutch | |
| Abridged model | 01/07/2007 | 20/11/2007 | 23/01/2008 | Dutch | |
| Abridged model | 01/07/2006 | 02/01/2007 | 25/01/2007 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
GENEVIEVE VANDERSTIGGEL | DirectorManagersince 09/07/1999ended | |
Geert Bosma | DirectorManagerended |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Genevieve VanderStiggel | Manager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution10/09/2026STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, ENZ,
- Mandates25/11/2022BENAMING - ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
- Capital / shares14/03/2018KAPITAAL - AANDELEN
- Mandates27/03/2015BENAMING - DOEL - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN
- Capital / shares12/03/2014KAPITAAL - AANDELEN - BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Registered office27/11/2009MAATSCHAPPELIJKE ZETEL
- Capital / shares28/10/2005ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Langeweg 1 bte B, 9992 Middelburg | CBE until 09/09/2026 | CBE |
| Lange Weg 1B, 9992 Middelburg | accounts 2025 | Accounts 2025 · 2026-00251455 |
| Lange Weg 1 bte B, 9992 Middelburg | accounts 2021 → 2024 | Accounts 2024 · 2025-00217781 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DOKTER GENEVIEVE VANDERSTIGGEL (NEFROLOGIE) – DOKTER GEERT BOSMA (PSYCHIATRIE) | CBE until 09/09/2026 | CBE |
| DOKTER GENEVIEVE VANDERSTIGGEL (NEFROLOGIE) - DOKTER GEERT BOSMA (PSYCHIATRIE) | accounts 2015 → 2025 | Accounts 2025 · 2026-00251455 |
| Dokter Genevieve VanderStiggel | accounts 2007 → 2014 | Accounts 2014 · 2015-01700148 |
Events
- 2025Annual accounts 2025124,1 k €↓
- 2024Annual accounts 2024198,1 k €↑
- 2023Annual accounts 202335,2 k €↑
- 2022Annual accounts 202230,6 k €↓
- 2021Annual accounts 2021116,2 k €↑
- 2020Annual accounts 202092,2 k €↑
- 2019Annual accounts 2019-2,6 k €↓
- 2018Annual accounts 201862,5 k €↑
- 2017Annual accounts 2017-3,6 k €↓
- 2016Annual accounts 20162,9 k €↓
- 2015Annual accounts 20157,3 k €↓
- 2015Name changeDOKTER GENEVIEVE VANDERSTIGGEL (NEFROLOGIE) - DOKTER GEERT BOSMA (PSYCHIATRIE)
- 2014Annual accounts 201414,4 k €↓
- 2013Annual accounts 201383 k €↑
- 2012Annual accounts 201259,8 k €↓
- 2011Annual accounts 201176,7 k €↑
- 2010Annual accounts 201043 k €↑
- 2009Annual accounts 200937,7 k €↓
- 2008Annual accounts 200875,9 k €↑
- 2007Annual accounts 200752,9 k €
- 09/07/1999IncorporationPrivate limited company